Home | Investors | ASX Announcements | 2021 ASX Announcements 2021 Date Document 30/08/2021 Preliminary Final Report 02/08/2021 Quarterly Activities/Appendix 4C Cash Flow Report 28/07/2021 Appointment of GM - Global Sales & Marketing 01/07/2021 Change of Director's Interest Notice 01/07/2021 Cancellation of Unlisted Options 30/06/2021 Controlled Placement Facility - Extension and Increase 28/06/2021 Change of Director's Interest Notice 28/06/2021 Appointment of Managing Director 11/06/2021 Secondary Trading Notice 11/06/2021 Application for quotation of securities - RHT 04/06/2021 Resignation of CEO & Management Changes 24/05/2021 Filing of Patent Application 17/05/2021 R&D Update - Molecular Medicine ASO Project 29/04/2021 Appendix 4C - quarterly 08/04/2021 Appointment of CFO & Company Secretary 09/03/2021 Change of Director's Interest Notice 09/03/2021 Secondary Trading Notice & Appendix 2A 26/02/2021 Half Yearly Report and Accounts 24/02/2021 HepaFat-AI receives CE Marking 18/02/2021 HepaFat-AI Receives TGA Approval 17/02/2021 Trading Halt 17/02/2021 Pause in Trading 28/01/2021 Appendix 4C - quarterly 12/01/2021 Secondary Trading Notice & Appendix 2A
